LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders

Published:2020-03-11 Issue:6 Volume:111 Page:851-857
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Hong Jian,Ni Jing,Ruan Min,Yang Mingzhen,Dong Qianggang,Li Qingsheng^ORCID

Funder

Young Scholar Program of The First Affiliated Hospital of Anhui Medical University

Provincial Natural Science Research Project of Colleges and Universities in Anhui Province

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-020-02844-7.pdf

Reference19 articles.

1. Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly P, Van Der Velden W, et al. Response to rituximab-based therapy and risk factor analysis in Epstein–Barr virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the infectious diseases working party of the european group for blood and marrow transplantation. Clin Infect Dis. 2013;57:794–802.

2. Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378:549–62.

3. Leen AM, Bollard CM, Mendizabal AM, Shpall EJ, Szabolcs P, Antin JH, et al. Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation. Blood. 2013;121:5113–23.

4. Styczynski J, Van Der Velden W, Fox CP, Engelhard D, De La Camara R, Cordonnier C, et al. Management of Epstein–Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica. 2016;101:803–11.

5. Saglio F, Hanley PJ, Bollard CM. The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care. Cytotherapy. 2014;16:149–59.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Status and Progress of CMV and EBV Infection after Allogeneic Hematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning;Advances in Clinical Medicine;2023

2. Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients;Current Opinion in Infectious Diseases;2022-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3